Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive 

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-28380

Steffel, J; Lüscher, T F (2009). Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors. Journal of Cardiovascular Medicine, 10(8):616-623.

[img]Accepted Version
PDF
1MB

Abstract

Vitamin K antagonists are the mainstay in the prevention and treatment of thromboembolic diseases. Although effective under optimal conditions, several drawbacks are imminent to the long-term application of these drugs due to their narrow therapeutic window, interactions with other drugs as well as the need for regular monitoring and the risk of a recurrent event versus the risk of bleeding. To overcome these downsides, novel anticoagulants are being developed; in contrast to vitamin K antagonists, these novel agents specifically and selectively block central elements of the coagulation cascade. Several clinical trials have demonstrated the efficacy and safety of selective FXa inhibitors (such as fondaparinux, rivaroxaban, apixaban) and direct thrombin inhibitors (such as lepirudin, bivalirudin, dabigatran etexilate) in the treatment of typical indications for conventional vitamin K antagonists, in particular, the prevention and treatment of venous thromboembolism. This review summarizes the results and designs of recently published and ongoing clinical trials of novel anticoagulants.

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiology
DDC:610 Medicine & health
Language:English
Date:2009
Deposited On:16 Mar 2010 07:47
Last Modified:27 Nov 2013 20:10
Publisher:Lippincott Wiliams & Wilkins
ISSN:1558-2027
Publisher DOI:10.2459/JCM.0b013e32832edac0
Related URLs:http://journals.lww.com/jcardiovascularmedicine/pages/articleviewer.aspx?year=2009&issue=08000&article=00005&type=abstract (Publisher)
PubMed ID:19561526
Citations:Web of Science®. Times Cited: 15
Google Scholar™
Scopus®. Citation Count: 20

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page